Shenker, R. F., Hughes, R. T., McTyre, E., Lanier, C. M., Lo, H. W., Metheny-Barlow, L., … Chan, M. D. (2018). Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who Receive upfront SRS Alone. International Journal of Radiation Oncology*Biology*Physics, 102(3), e292–e292. https://doi.org/10.1016/j.ijrobp.2018.07.926

Shenker, R. F., R. T. Hughes, E. McTyre, C. M. Lanier, H. W. Lo, L. Metheny-Barlow, A. Thomas, et al. “Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who Receive upfront SRS Alone.” International Journal of Radiation Oncology*Biology*Physics 102, no. 3 (November 2018): e292–e292. https://doi.org/10.1016/j.ijrobp.2018.07.926.

Shenker RF, Hughes RT, McTyre E, Lanier CM, Lo HW, Metheny-Barlow L, et al. Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who Receive upfront SRS Alone. International Journal of Radiation Oncology*Biology*Physics. 2018 Nov;102(3):e292–e292.

Shenker, R. F., et al. “Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who Receive upfront SRS Alone.” International Journal of Radiation Oncology*Biology*Physics, vol. 102, no. 3, Elsevier BV, Nov. 2018, pp. e292–e292. Crossref, doi:10.1016/j.ijrobp.2018.07.926.

Shenker RF, Hughes RT, McTyre E, Lanier CM, Lo HW, Metheny-Barlow L, Thomas A, Brown DR, Avery T, Pasche B, Cramer CK, Tatter SB, Laxton A, Watabe K, Chan MD. Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who Receive upfront SRS Alone. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018 Nov;102(3):e292–e292.